Table 3 Adverse events between patients with and without systemic corticosteroids
Systemic corticosteroids (n = 47, %) | Without corticosteroids (n = 26, %) | P value | |
|---|---|---|---|
Hyperglycemia with additional glucose-lowering therapy | 17 (36.2) | 7 (26.9) | 0.45 |
New infection | 13 (27.7) | 6 (23.1) | 0.78 |
GIB | 1 (2.1) | 0 (0) | 1.00 |